Lupin to attend Motilal Oswal's 21st annual global investor conference

Lupin Limited informed the National Stock Exchange of India and BSE Limited on August 27, 2025, of its upcoming participation in an analyst/institutional investors meet. The pharmaceutical company will attend the Motilal Oswal - 21st annual global investor conference on September 03, 2025. This engagement will be conducted in person and is scheduled as a group meeting.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Lupin specified that the date of the event is subject to change based on exigencies from either the company or the event organizer.

Furthermore, any presentation made at the conference will align with materials already accessible on the company's and relevant stock exchanges' websites. The announcement was signed by Amit Kumar Gupta, company secretary & compliance officer, affirming the company's commitment to transparent investor communication.